sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology plc
The Vanguard Group, Inc. has released a disclosure under Rule 8.3 of the Irish Takeover Panel Act, regarding its position in Mural Oncology plc. As of August 25, 2025, Vanguard holds 4.47% of Mural Oncology's $0.01 ordinary shares, amounting to 771,539 shares. This disclosure is crucial for transparency in the context of takeover regulations.
In recent dealings, Vanguard reported the sale of 32 ordinary shares at a unit price of $2.06. No derivative transactions or other dealings involving Mural Oncology's securities have been disclosed. Additionally, Vanguard stated no indemnity or option arrangements related to these securities.
No supplemental Form 8 accompanies this disclosure, indicating no new agreements or derivative transactions. Such disclosures are standard practice for entities with significant interests in relevant securities.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.